Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Divi's Laboratories Limited
  6. Summary
    DIVISLAB   INE361B01024

DIVI'S LABORATORIES LIMITED

(DIVISLAB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
09/14/2021 09/15/2021 09/16/2021 09/17/2021 09/20/2021 Date
5094.85(c) 5158.9(c) 5166.9(c) 5122.8(c) 5130 Last
521 157 336 784 289 942 401 270 409 438 Volume
+0.19% +1.26% +0.16% -0.85% +0.14% Change
More quotes
Estimated financial data (e)
Sales 2022 83 413 M 1 132 M 1 132 M
Net income 2022 25 202 M 342 M 342 M
Net cash position 2022 26 681 M 362 M 362 M
P/E ratio 2022 54,6x
Yield 2022 0,50%
Sales 2023 98 406 M 1 336 M 1 336 M
Net income 2023 30 330 M 412 M 412 M
Net cash position 2023 34 926 M 474 M 474 M
P/E ratio 2023 45,8x
Yield 2023 0,57%
Capitalization 1 360 B 18 457 M 18 464 M
EV / Sales 2022 16,0x
EV / Sales 2023 13,5x
Nbr of Employees 16 818
Free-Float 47,6%
More Financials
Company
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India. 
Sector
Pharmaceuticals
Calendar
11/08Earnings Release
More about the company
Ratings of Divi's Laboratories Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DIVI'S LABORATORIES LIMITED
09/08Indian Indices End in Red Midweek; Nestle India Drops 3%
MT
08/30Divi's Laboratories Limited Declares Dividend for the Financial Year Ended Ma..
CI
08/17DIVI'S LABORATORIES LIMITED : Ex-dividend day for final dividend
FA
08/08DIVI LABORATORIES' : Consolidated Profit Climbs in Fiscal Q1
MT
08/07Divi's Laboratories Limited Reports Earnings Results for the First Quarter En..
CI
07/20Divi's Laboratories Limited Recommends a Dividend for the Financial Year 2020..
CI
07/19Indian Indices Close Lower on Monday, Dragged Down by Financial Stocks; HDFC ..
MT
07/16Indian Benchmarks Close the Week in Red; HCL Technologies Slumps 3%
MT
07/16Information Technology Stocks Drag Indian Indices to Close Slightly Lower on ..
MT
06/30Indian Benchmarks Close in Red on Wednesday; Information Technology Stocks Ga..
MT
06/23Indian Indices Snap Two-Day Gains on Wednesday; Adani Ports Shares Slump 3%
MT
05/31DIVI LABORATORIES' : Consolidated Profit Jumps in Fiscal Q4
MT
05/29Divi's Laboratories Limited Recommends Dividend for the Financial Year 2020-2..
CI
05/29Divi's Laboratories Limited Reports Earnings Results for the Fourth Quarter E..
CI
05/26DIVI LABORATORIES : MSD Allows Divi's Laboratories to Manufacture, Supply Molnup..
MT
More news
News in other languages on DIVI'S LABORATORIES LIMITED
09/08Les indices indiens terminent dans le rouge en milieu de semaine ; Nestlé Ind..
More news
Chart DIVI'S LABORATORIES LIMITED
Duration : Period :
Divi's Laboratories Limited Technical Analysis Chart | DIVISLAB | INE361B01024 | MarketScreener
Technical analysis trends DIVI'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 5 122,80 INR
Average target price 4 925,06 INR
Spread / Average Target -3,86%
EPS Revisions
Managers and Directors
Satchandra Kiran Divi Chief Executive Officer & Executive Director
L. Kishore Babu Chief Financial Officer
Ramesh B. V. Nimmagadda Non-Executive Chairman
L. Ramesh Babu Chief Information Officer & VP-Procurement
Ramesh Babu M. General Manager-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
DIVI'S LABORATORIES LIMITED33.34%18 457
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604